News
20 February 2026
From Quality to Public Trust
In the healthcare industry, public trust is not built overnight. It grows through consistent quality assurance, adherence to standards, and contributions that are tangibly felt by society. As demands for transparency continue to rise, healthcare companies are expected not only to deliver good products, but also to establish accurate and…
3 February 2026
Dexa Medica Receives the 2026 BPOM Achievement Award as Indonesia’s Leading Phytopharmaceutical Company
Dexa Medica has once again affirmed its role as a pioneer in Indonesia’s pharmaceutical industry through an award presented by the National Agency of Drug and Food Control (BPOM) of the Republic of Indonesia. The BPOM Achievement Award 2026 in the category of Pioneer with the Highest Number of Phytopharmaceutical…
30 January 2026
Dexa Group’s Consistent Reputation Management Wins the 8th Indonesia Public Relations Awards
Winning the award for eight consecutive times, Dexa Group demonstrates long-term consistency in building public trust. This commitment has once again led Dexa Group to receive the Indonesia Public Relations Awards (IPRA) 2026 with the title of Best Public Relations 2026 in Public Trust Building through Ethical Pharmaceutical Practices. This…
16 October 2025
30,000 Medicinal Plants, Only 20 Phytopharmaceuticals: Dexa Medica Strengthens Indonesia’s Role at the 16th WHO–IRCH Global Forum
Dexa Medica once again demonstrates its strong commitment as a national pharmaceutical company that plays a vital role in strengthening Indonesia’s pharmaceutical independence, particularly through the development of natural-based medicines. This commitment was reflected in its active contribution to the prestigious 16th Annual Meeting of the WHO–International Regulatory Cooperation for…
2 October 2025
Dexa Group Receives Two Prestigious Awards in One Day for Its Commitment to Halal Assurance Across All Products and Facilities
Dexa Group achieved a remarkable milestone by receiving two prestigious awards in a single day, underscoring its commitment to ensuring halal assurance across all products and facilities. The recognitions came from Indonesia’s Ministry of Industry (Kemenperin) and the Halal Inspection Body of the Institute for Food, Drug, and Cosmetic Studies…
2 October 2025
More Than 1,500 Residents Join Dexa Medica’s Free Health Check, Reinforcing Commitment to Quality and Halal Medicine Access
Non-Communicable Diseases (NCDs) such as hypertension, diabetes, and high cholesterol are increasingly becoming a threat to public health in Indonesia. These three silent killers often show no symptoms, yet have serious impacts on quality of life and healthcare costs. Responding to this challenge, PT Dexa Medica, through its Cek Segitiga…
24 September 2025
Building Reputation through The Reflection of Quality, Dexa Medica Wins Indonesia Most Reputable Companies Award 2025
Dexa Medica has once again received the prestigious Indonesia Most Reputable Companies Award 2025 from SWA Magazine and Business Digest. This marks the second time Dexa Medica has earned this recognition, reaffirming the company’s commitment to building and maintaining its reputation as a reflection of quality. The award was presented…
24 September 2025
Reflection of Quality and Innovation in Industry 4.0, Dexa Medica Wins Rintek 2025 Award
Dexa Medica has been awarded the 2025 Industrial Technology Pioneer Award (Rintek) in the category of Technology Pioneer Evaluation Results by the Ministry of Industry of the Republic of Indonesia. The award recognizes the success of Inlacin, an Indonesian Original Modern Medicine for diabetes, as a clinically proven global innovation…
24 September 2025
Dexa Medica Health Screening Program: Early Detection of Hypertension, Diabetes, and Cholesterol
Non-Communicable Diseases such as hypertension, diabetes, and high cholesterol are increasingly threatening public health in Indonesia. According to the Ministry of Health of the Republic of Indonesia, these three silent diseases are among the leading contributors to the national health burden and are often detected only when it is too…
15 August 2025
Dexa Group Wins Indonesia PR of The Year 2025, A True Reflection of Quality
JAKARTA — Strategic and impactful public communication has once again placed Dexa Group on the national stage. The pharmaceutical company has been named Indonesia PR of The Year 2025 by MIX MarComm magazine. The award was presented by MIX MarComm’s Editor-in-Chief, Ms. Lis Hendriani, to Dexa Group’s Head of Corporate…